CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | CRAVES FRED B Director | Sale | −1,200 | $350.71 | $421K | 14,600 |
| 2024-11-21 | Huntsman Carole Chief Commercial Officer | Sale | −688 | $316.92 | $218K | 10,785 |
| 2024-11-07 | Levy Richard S Director | Option exercise 10b5-1 | +5,000 | $7.36 | $37K | 16,012 |
| 2024-11-07 | Levy Richard S Director | Sale 10b5-1 | −5,000 | $350.00 | $1.8M | 11,012 |
| 2024-11-07 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 5,000 | ||
| 2024-11-01 | Levy Richard S Director | Option exercise 10b5-1 | +5,000 | $7.36 | $37K | 16,012 |
| 2024-11-01 | Levy Richard S Director | Sale 10b5-1 | −2,800 | $300.10 | $840K | 13,212 |
| 2024-11-01 | Levy Richard S Director | Sale 10b5-1 | −1,100 | $301.22 | $331K | 12,112 |
| 2024-11-01 | Levy Richard S Director | Sale 10b5-1 | −800 | $302.25 | $242K | 11,312 |
| 2024-11-01 | Levy Richard S Director | Sale 10b5-1 | −300 | $304.29 | $91K | 11,012 |
| 2024-11-01 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 10,000 | ||
| 2024-09-13 | CRAVES FRED B Director | Gift | −15,000 | 360,076 | ||
| 2024-09-09 | Sibold William John President and CEO | Sale | −6,363 | $243.83 | $1.6M | 55,887 |
| 2024-08-15 | Kelley Shannon T General Counsel | Grant or award | +5,215 | 7,982 | ||
| 2024-08-15 | Kelley Shannon T General Counsel | Grant or award · Stock Option (Right to Buy) | +7,820 | 7,820 | ||
| 2024-06-25 | CRAVES FRED B Director | Grant or award | +714 | 375,076 | ||
| 2024-06-25 | CRAVES FRED B Director | Grant or award · Stock Option (Right to Buy) | +1,105 | 1,105 | ||
| 2024-06-25 | BATE KENNETH Director | Grant or award | +714 | 1,912 | ||
| 2024-06-25 | BATE KENNETH Director | Grant or award · Stock Option (Right to Buy) | +1,105 | 1,105 | ||
| 2024-06-25 | Daly James M Director | Grant or award | +714 | 1,912 |
Page 28 of 82 · 1,629 trades